ZINPLAVA
- Product NDC
- 0006-3025
- Requested package NDC
- 0006-3025-00
- 11-digit product format
- 000063025
- Labeler code
- 0006
- Product ID
- 0006-3025_1302e606-55e6-42a4-aab1-4d16f1823397
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bezlotoxumab
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Merck Sharp & Dohme LLC
- Application
- BLA761046
- Marketing category
- BLA
- Marketing start
- 2016-10-21
- Substance
- BEZLOTOXUMAB
- Active strength
- 25 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ZINPLAVA
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BEZLOTOXUMAB | 25 mg/mL |
Harmonized UNII identifiers#
UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table| Identifier | FDA.report destination |
|---|
| 4H5YMK1H2E | Internal UNII lookup |
Harmonized RxCUI identifiers#
RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table| Identifier | FDA.report destination |
|---|
| 1855052 | Internal RxNorm lookup |
| 1855057 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0006-3025-00 | ZINPLAVA | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 12 |
| 0006-3025-01 | ZINPLAVA | 40 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 40 | | 12 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0006-3025 | ZINPLAVA (BEZLOTOXUMAB) INJECTION, SOLUTION [MERCK SHARP & DOHME LLC] | 11 | Current NDC, Legacy NDC, 2 package rows | 20241129_8f479bfe-2bfa-4cc5-9aee-1357364480b0.zip |
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 761046 | Zinplava | bezlotoxumab | 351(a) | Rx | 2026-10-01 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0006-3025-00 | 00006302500 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3025-00) / 40 mL in 1 VIAL, SINGLE-DOSE (0006-3025-01) | 2016-10-21 | 0000-00-00 | No | No | Current |